
### [NCIT:C35873](http://purl.obolibrary.org/obo/NCIT_C35873)
**Label:** Iatrogenic Kaposi Sarcoma

**Subclasses:** [NCIT:C27640](http://purl.obolibrary.org/obo/NCIT_C27640) (Transplant-Related Kaposi Sarcoma), [NCIT:C9113](http://purl.obolibrary.org/obo/NCIT_C9113) (Kaposi Sarcoma Related to Immunosuppressive Treatment), 

**Class expressions from DL-Learner:**

- Thing 54.31%
- [NCIT:C53413](http://purl.obolibrary.org/obo/NCIT_C53413) (Malignant Oval Endothelial Cell) 51.72%
- [NCIT:C53405](http://purl.obolibrary.org/obo/NCIT_C53405) (Malignant Spindle Endothelial Cell) 51.72%
- [NCIT:C37092](http://purl.obolibrary.org/obo/NCIT_C37092) (Spindle Endothelial Cell) and [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) 51.72%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40261](http://purl.obolibrary.org/obo/NCIT_C40261) (Vaginal Adenoid Cystic Carcinoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40260](http://purl.obolibrary.org/obo/NCIT_C40260) (Vaginal Adenosquamous Carcinoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40259](http://purl.obolibrary.org/obo/NCIT_C40259) (Vaginal Villous Adenoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40258](http://purl.obolibrary.org/obo/NCIT_C40258) (Vaginal Tubulovillous Adenoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40257](http://purl.obolibrary.org/obo/NCIT_C40257) (Vaginal Tubular Adenoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40255](http://purl.obolibrary.org/obo/NCIT_C40255) (Vaginal Mullerian Papilloma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40252](http://purl.obolibrary.org/obo/NCIT_C40252) (Vaginal Mucinous Adenocarcinoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40251](http://purl.obolibrary.org/obo/NCIT_C40251) (Vaginal Endometrioid Adenocarcinoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40248](http://purl.obolibrary.org/obo/NCIT_C40248) (Vaginal Warty Carcinoma))) 48.47%


